Get the StoQuant digest — free
Free StoQuant digest by email. No account needed.
See today's research picks.
CCAP vs CEPT — Stock Comparison
Compare CCAP and CEPT side-by-side on StoQuant: CCAP Q-Score 4 vs CEPT 62; analyst signal 65 vs 75. Plus alt data signals, insider buying, catalysts, strategic edges, short interest, social sentiment, and macro context.
Side-by-side snapshot
- CCAP — Crescent Capital BDC, Inc. · Financials · market cap $319M · Q-Score verdict Strong Sell (4.0, grade F) · analyst signal 65/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: valuation 70/100, earnings quality 59/100 · weakest signals: analyst consensus 46/100, technicals 4/100. Full CCAP research.
- CEPT — Cantor Equity Partners II, Inc. Class A Ordinary Share · Financials · market cap $290M · Q-Score verdict Buy (62.0, grade B) · analyst signal 75/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: analyst consensus 87/100, technicals 70/100. Full CEPT research.
What you can compare
- Q-Score: StoQuant's composite 0–100 rating based on 140+ financial signals.
- Alt data signals: Google Trends, EDGAR 8-K filings, job postings, and more.
- Insider activity: Cluster scores and recent Form 4 buying.
- Catalysts: Earnings, analyst changes, M&A, clinical trials, and SEC events.
- Strategic edges: Competitive moat and durable advantage analysis.
- Short interest & social sentiment: Short % float, social mention volume, and bullish/bearish breakdown.
- Macro context: Market regime and sector rotation alignment.
Deep dive: CCAP research · CEPT research. Sign in to StoQuant to run live comparisons for any tickers. Sign up free →
Register founding interest — Pro $29/mo or Power $79/mo
Paid plans aren’t for sale yet. Leave your email to lock founding pricing (Pro $29, Power $79); we’ll reach out personally.